Status:
COMPLETED
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Lead Sponsor:
UCB Pharma
Conditions:
Allergies
Eligibility:
All Genders
2-12 years
Brief Summary
This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The...
Eligibility Criteria
Inclusion
- Children from 2-12 included
- History of allergy
- Used an Antihistamine within market authorization
Exclusion
- Child not yet treated for the presented allergy
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
4581 Patients enrolled
Trial Details
Trial ID
NCT00453583
Start Date
March 1 2007
End Date
January 1 2008
Last Update
December 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCB Pharma
Smyrna, Georgia, United States